Metabolomics reveals LysoPC a C17:0 (LPC 17:0) as candidate biomarker for personalized medicine in morbid obesity
代谢组学研究表明，溶血磷脂酰胆碱（LysoPC a C17:0，简称LPC 17:0）可作为病态肥胖个体化治疗的候选生物标志物。
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1779275
Stefanini, Eleonora; Marin, Silvia; Serrano-Marín, Joan; Sánchez-Navés, Juan; Alkozi, Hanan Awad; Pallàs, Mercè; Cascante, Marta; Griñán-Ferré, Christian; Franco, Rafael
